LSD-potentiated apomorphine hypermotility: A model for differentiating antipsychotic drugs
- 31 December 1982
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 18 (1) , 13-17
- https://doi.org/10.1016/0091-3057(83)90243-5
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: Drug interaction at presynaptic receptors?European Journal of Pharmacology, 1980
- Neuroleptic interaction with the serotoninergic-dopaminergic mechanisms in the nucleus accumbensJournal of Pharmacy and Pharmacology, 1978
- Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviourLife Sciences, 1978
- Antipsychotic Drugs, Neurotransmitters, and SchizophreniaAmerican Journal of Psychiatry, 1978
- Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic systemJournal of Pharmacy and Pharmacology, 1976
- Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazineEuropean Journal of Pharmacology, 1976
- The behavioural effects of dopamine applied intracerebrally to areas of the mesolimbic systemEuropean Journal of Pharmacology, 1975
- Clozapine and the Dopamine Hypothesis of Schizophrenia, a Critical AppraisalPharmacopsychiatry, 1975
- Mesolimbic involvement with behavioural effects indicating antipsychotic activityEuropean Journal of Pharmacology, 1974
- Dopamine turnover in the corpus striatum and the limbic system after treatment with neuroleptic and anti-acetylcholine drugsJournal of Pharmacy and Pharmacology, 1972